REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Elanda Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Fats and Oils Refining and Blending | Coffee and Tea Manufacturing | All Other Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Grocery and Related Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Elanda Pharma Sp. z o.o. Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Elanda Pharma is a Polish company with over 25 years of experience in manufacturing medications, foodstuffs, and dietary supplements. They are licensed to manufacture and process group I - N narcotics, group II - P psychotropic substances, and veterinary products. The company provides services for non-sterile medical devices, repackaging and labeling medicinal products, medical devices, dietary supplements, foodstuffs, and cosmetics.

Headquarters
Ul. Sportowa 9
Rozprza; Lodzkie; Postal Code: 97-340

Contact Details: Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Website: http://www.elanda.pl

Basic Information
Total Employees:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 10, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Elanda Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
22.34%▲
Total operating revenue
21.79%▲
Operating profit (EBIT)
-200.89%▼
EBITDA
N/A
Net Profit (Loss) for the Period
-169.06%▼
Total assets
-3.66%▼
Total equity
N/A
Operating Profit Margin (ROS)
-17.77%▼
Net Profit Margin
-20%▼
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo